Stanford Cancer Institute Breakthroughs in Cancer: Charles Sawyers, MD - YouTube
youtube.com · 10,298 words · saved by 1 readers
Follow along using the transcript. Follow along using the transcript. New New LIVE New 4K CC CC
Topic: Topic: Head and Neck Cancer Translational Medicine Memorial Sloan Kettering physician-scientist Charles Sawyers, MD, specializes in new drug development for leukemias, prostate cancer, and glioblastoma. He has identified cell signaling components critical to the growth of cancer cells in chronic myeloid leukemia, prostate and other cancers, resulting in the development of multiple FDA-approved inhibitors in clinical use today. Breakthroughs in Cancer seminar series is one of the highest-profile seminar series for translational and clinical scientists in oncology. The series brings…
saved by
related reading
- Loss and revival of androgen receptor signaling in advanced prostate cancernature.com
- Epigenetic regulation during cancer transitions across 11 tumour typesnature.com
- Going Founder Mode On Cancer - by Elliot Hershbergcenturyofbio.com
- Context is everything: Aneuploidy in canceryoutube.com
- Cancersytse.com
- Has pancreatic cancer met its match?worksinprogress.co
- Going Founder Mode On Cancercenturyofbio.com
- The current state of the art and future trends in RAS-targeted cancer therapiesnature.com
- Medicine's Endgamenotboring.co
- The blood cancer that became solvableworksinprogress.news
- The race to catch KRAS, pancreatic cancer’s ‘greasy ball,’ and create the most promising drug in decadesstatnews.com
- Immunotherapy for Cancer - NCIcancer.gov